A recent scientific study conducted by researchers at Rockefeller University revealed a promising role for the amino acid arginine in enhancing the immune system’s ability to detect cancer cells and fight viral infections, as experiments showed that increasing its levels helped reduce colon cancer tumors and improve outcomes from influenza and the SARS-CoV-2 coronavirus in mice. According to ScienceDaily, the study found that a decrease in arginine levels could disrupt one of the immune system’s key mechanisms for recognizing abnormal cells infected with viruses, allowing these cells to evade immune surveillance. Arginine is an essential amino acid for immune system efficiency. The researchers explained that arginine is an amino acid that the body produces naturally, as well as receives from protein-rich foods, and plays a key role in the production of proteins essential for many body functions. The study revealed that a deficiency of this amino acid affects the production of a protein known as MHC-I, which is an important component of the immune surveillance system, as it helps immune cells, especially T cells, recognize abnormal proteins resulting from viral infections or cancerous mutations. The researchers pointed out that a decrease in arginine levels leads to a disruption in the production of this protein, which reduces the signals that help the immune system detect infected or cancerous cells. A deficiency of arginine may give cancer cells a chance to escape. The researchers explained this mechanism by stating that a deficiency of arginine affects the functioning of ribosomes, which are the components responsible for protein production within cells, leading to a disruption in the production of MHC-I proteins and a lower amount reaching the cell surface. As a result, abnormal cells become less capable of displaying the signals that reveal them to the immune system, which may give cancer cells a chance to escape detection by T cells. The researchers observed a decrease in the levels of 414 proteins when arginine was deficient in laboratory experiments, including proteins associated with immune functions and the recognition of abnormal cells. Experiments reveal a decline in colon cancer tumors In experiments conducted on mice, the researchers found that animals that consumed low-arginine diets developed a greater number of colon cancer tumors, while mice that received higher amounts of arginine developed fewer tumors. The results indicate that the availability of arginine may affect cancer development by improving the immune system’s ability to recognize cancer cells, and not only through its direct effect on the cells themselves. A surprise finding: Arginine improves influenza and coronavirus outcomes In addition to cancer, the results did not stop there. The researchers tested the effect of arginine in animal models of influenza and SARS-CoV-2 infection. The experiments showed that mice that received higher amounts of arginine experienced less severe symptoms when infected with the viruses compared to animals that received lower amounts. In a surprising result, the researchers found that giving arginine to mice after they had already been infected with the influenza virus also improved their outcomes, indicating that the availability of this amino acid may affect the immune response even after infection has occurred. Could arginine become an adjuvant treatment for cancer and viruses? The researchers believe that these results could open the door to studying the use of arginine in combination with immune therapies for cancer, especially since these therapies rely on enhancing the immune system’s ability to recognize and attack cancer cells. The scientists also suggest studying the potential use of arginine supplements in populations at higher risk of viral infections, especially since its levels may naturally decrease with age and may also be affected by poor nutrition. Medical warning: The results do not mean that the supplement cures cancer Despite the promising results, the study was conducted on animal models and laboratory experiments, and it has not yet been proven that taking arginine supplements prevents cancer or treats influenza and COVID-19 in humans. The researchers emphasized the importance of conducting clinical trials to determine the effectiveness, safety, and appropriate doses of the supplements before recommending their use for prevention or treatment.
Promising experience: A dietary supplement that helps the immune system fight cancer and viruses

AdvertisementAdvertisement appears here
